MARKET REPORT: Skyepharma in a jam over asthma drug – This is Money


This is Money

MARKET REPORT: Skyepharma in a jam over asthma drug
This is Money
was run by its controversial founder Ian Gowrie Smith, who then had a history of over-promising and under-delivering, the City was up in arms after he announced a shock deeply-discounted £35m rights issue to develop Flutiform, its asthma treatment.
SkyePharma's Asthma Treatment Faces European Approval Delay; Shares FallRTT News
SkyePharma hit with European delay on Flutiform appFierceDrugDelivery
SkyePharma lung drug faces European approval delayReuters UK

all 10 news articles »

View full post on asthma – Google News

American Lung Association hosts Fight for Air Climb to raise money and awareness – FOX19

American Lung Association hosts Fight for Air Climb to raise money and awareness
FOX19
According to the ALA, 35 million Americans are living with chronic lung diseases such as asthma, lung cancer, and COPD. The economic cost of asthma alone is over $19 billion each year. In Ohio, 52 people die each day from tobacco related disease and 57

and more »

View full post on asthma – Google News